US2008008661A1PendingUtilityA1
Methods and compositions for treating erectile dysfunction
Est. expiryMay 4, 2019(expired)· nominal 20-yr term from priority
Inventors:Reid M. RubsamenRobert ColeJames BlanchardJeffrey A. SchusterLawrence LinnJohn Thipphawong
A61P 15/10A61K 31/519A61K 31/496A61K 31/565A61K 38/2278A61P 15/12A61K 45/06A61K 38/095A61K 9/0075A61K 38/51A61K 9/008A61K 9/0073A61K 31/568
58
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods are provided for increasing libido and/or treating erectile dysfunction in a man. The methods include the administration of a formulation testosterone alone, another fast-acting drug to treat erectile dysfunction or a combination of the testosterone and the other drug where at least one is delivered by aersolization. The formulation is preferably aerosolized and inhaled into a patient's lungs where particles of testosterone and/or the fast-acting erectile dysfunction drug deposits on lung tissue and then enter the patient's circulatory system.
Claims
exact text as granted — not AI-modified1 .- 18 . (canceled)
19 . A kit for the treatment of erectile dysfunction in a man, comprising:
a hand-held device for the aerosolized delivery of a formulation; a container of an aerosolizable formulation comprising sildenafil.
20 . The kit of claim 19 , further comprising:
a plurality of containers of aerosolizable formulation of sildenafil.
21 . The kit of claim 20 , wherein each of the containers of sildenafil comprises 25 mg of aerosolizable sildenafil.
22 . The kit of claim 20 , wherein each of the containers of sildenafil comprises 25 mg to 100 mg of aerosolizable sildenafil.
23 . The kit of claim 19 , comprising from 1 to 100 containers of aerosolizable formulation of sildenafil.
24 . The kit of claim 19 , comprising from 1 to 30 containers of aerosolizable formulation of sildenafil.Join the waitlist — get patent alerts
Track US2008008661A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.